BFST

Analyst Note: BFST (Business First Bancshares, Inc.)

Date: 2026-06-13 Current Price: $28.77

1. Structural Readiness

• Conservative Entry: Not yet defined (requires confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not applicable for a confirmed setup; currently in the accumulation/formation phase.
• Breakout Level: Not explicitly defined in the provided text; requires identification of the resistance level above the current consolidation.
• Current Price: $28.77.
• Extension: Not applicable (price is not extending from a confirmed breakout).
• ATR Context: Current ATR is 2.2% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting a tighter, potentially slower-moving setup.

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Criteria: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals (earnings guidance, recent M&A integration, and operational efficiency). Do not invent a macro narrative; the conviction rests on the execution of the current business cycle and the structural breakout potential.

3. Business Overview

Business Model & Industry: BFST operates as a bank holding company for b1BANK, a Louisiana state-chartered bank. The company serves small-to-midsized businesses (SMBs) and professionals with credit needs between $1 million and $10 million, a segment described as "underserved" by larger institutions but too complex for traditional community banks.

• Primary Markets: Louisiana, the Dallas/Fort Worth metroplex, and Houston, Texas.
• Loan Portfolio: Primarily commercial loans and real estate loans secured by commercial real estate properties.
• Deposit & Services: Offers a full suite of deposit products (checking, money market, CDs), wealth management, and treasury/cash management services.

Key Operational Developments (as of source dates ≤ 2026-06-13):

• M&A Integration: The company completed the merger of Progressive Bank (parent: Progressive) on January 1, 2026, adding over $700 million in assets and 9 branches in North Louisiana. This follows the Oakwood Bank merger consummated on October 1, 2024.
• Strategic Partnerships: On February 17, 2026, BFST announced a strategic partnership with Covecta to deploy "agentic AI" across daily workflows.
• Capital Structure: On April 2, 2026, the company completed an $85.0 million private placement of subordinated notes (6.50% fixed-to-floating rate, due 2036).
• Financial Performance (Q1 2026):
• Net Interest Income: $75.2 million (up 14.0% YoY).
• Loan Growth Guidance: Management expects mid-single digits (6%–8%) for the full year, with acceleration to high single digits (8%–10%) in Q2 and Q3.
• ROAA Guidance: Reiterated forecast of a 1.25% ROAA end-of-year run rate.
• Margin Outlook: Core margin expected to tick up to the low-to-mid single digits.
• Cost Synergies: Expecting $11 million in annualized cost savings from the Progressive merger.
• Discount Accretion: Expected to be in the low $1 million range for the balance of 2026.
• Regional Catalysts: Management notes accelerated construction on a Meta data center project in Northeast Louisiana, positioning the bank to capture tens of billions in private investment in the region.

4. Archetype & Conviction

• Archetype: Growth Leader.
• *Fit:* The company is demonstrating top-line growth (14% NII increase, 6-8% loan growth guidance) driven by successful M&A integration (Progressive) and organic expansion in high-growth corridors (I-20, I-10/12). The deployment of AI and the capture of data center-related investment suggest a modernization and expansion narrative consistent with a growth leader archetype.
• Valuation Context:
• Forward consensus EPS (FY1): $2.99.
• Forward consensus EPS (FY2): $3.252.
• Implied P/E (based on $28.77 price): ~9.6x FY1.
• Conviction Stack:
• Thesis Strength: Moderate. Lacks a named secular macro thesis but has strong tactical business drivers.
• Evidence Quality: High. Recent earnings transcripts (April 2026) and SEC filings (May 2026) provide specific, quantified guidance on growth, margins, and cost synergies.
• Rerating Potential: Dependent on the successful integration of the Progressive merger and the realization of the $11M cost synergies. The Meta data center catalyst provides a potential regional re-rating catalyst if execution holds.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• Deterioration in loan growth guidance (missing the 6-8% target) or a decline in ROAA below the 1.25% run rate.
• Failure to realize the projected $11M cost synergies from the Progressive merger.
• What Would Strengthen:
• A confirmed breakout above the resistance level (firing the coil).
• Confirmation of the "high single digits to 10%" loan growth in Q2/Q3 as guided.
• Positive updates on the Meta data center project's impact on local deposit/loan capture.
• Gaps in Evidence:
• Breakout Level: The specific resistance price required to confirm the breakout is not explicitly stated.
• Detailed Balance Sheet Metrics: While total assets ($8.2B) and loans ($6.2B) are known as of Dec 31, 2025, specific Q1 2026 balance sheet composition (e.g., NPL ratios, specific CRE exposure breakdown) is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 14% YoY increase in Net Interest Income to $75.2M; Reiterated 1.25% ROAA run rate guidance; $11M annualized cost synergy target from Progressive merger; Strategic AI partnership with Covecta. Sizing hint: Position size should reflect the "forming" nature of the setup and the sub-threshold volatility; treat as a partial position until breakout confirmation. Expected path: Management expects loan growth to accelerate to high single digits in Q2/Q3, core margins to tick up, and cost synergies to materialize, potentially driving the price toward a breakout if the forming structure holds. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.